Week of May 2, 2022 | Vol. 11, Issue 18 |
|
|
In This Issue
Upcoming Events
Industry M&A Activity
Recent Transactions
Trading Comps
Market Reports
M&A Pipeline
Featured Headlines
Tanner Updates
Quick Links
Contact Information
Managing Director
Business Development
Managing Director
Head of M&A and Capital Advisory
|
|
Above is an overview of recent industry M&A activity. Click on the chart to download complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
|
|
Events Hosted or Attended by Bourne Partners
|
|
|
|
May 17-19, 2022 - Philadelphia, PA
|
|
|
|
May 24-26, 2022 - New York City, NY
|
|
|
|
June 13-16, 2022 - San Diego, CA
|
|
|
|
June 19-23, 2022 - Chicago IL
|
|
|
|
August 27-29, 2022 - Boston, MA
|
|
|
|
October 2022 - Charlotte, NC
|
|
INDUSTRY M&A ACTIVITY
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
|
|
RECENT TRANSACTIONS
An Overview of Transactions Within Market Sub-segments
|
|
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions. |
|
|
|
Pharma & Biotech
9 transactions totaling $699 million
Supplies, Equipment & Services
26 transactions totaling $261 million
Healthcare IT & Managed Care
3 transactions totaling $1 million
Healthcare Facilities & Distributors
4 transactions
|
|
|
|
Pharma & Biotech
22 transactions totaling $495 million
Supplies, Equipment & Services
26 transactions totaling $392 million
Healthcare IT & Managed Care
16 transactions totaling $410 million
Healthcare Facilities & Distributors
5 transactions totaling $3 million
|
|
|
|
Pharma & Biotech
16 transactions totaling $864 million
Supplies, Equipment & Services
2 transactions totaling $7 million
Healthcare IT & Managed Care
2 transactions totaling $1,295 million
Healthcare Facilities & Distributors
0 transactions
|
|
TRADING COMPS
A Breakdown of Relevant Trading Multiples
|
|
|
|
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.
For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table.
Note: data reflects prior week close.
|
|
MARKET REPORTS
Insight Into Healthcare Related Industries
|
|
M&A PIPELINE
Representative Current Retained Sell-Side And Partnering Opportunities
|
|
Project Gateway
Sell-side | Pharma | Generic pharmaceuticals
Project Nucleus
Buy-side| CDMO | North American radiopharmaceutical company
Project Panther
[Buy/sell]-side| [Pharma, CDMO, Generic Pharma, etc.] | [What the company does]
|
|
Project Power Play
Buy-side | Specialty Pharma | In-license and acquire approved Rx products including legacy brands, generics, and niche launch-ready products
Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics
|
|
FEATURED HEADLINES
A Sampling of Industry Headlines From Last Week
|
|
For years, drug prices have been on the rise, leaving as many as 18 million Americans struggling to pay for necessary prescriptions.
A drug pricing provision of the Build Back Better Act, which passed in the House of Representatives last year but stalled in the Senate, would cap certain price hikes and allow Medicare to negotiate lower prices for some drugs.
But Mark Thierer, former CEO of pharmacy benefit manager OptumRx, thinks the industry needs to take a different approach.
"The notion of overlaying a set of government programs to mandate price controls, in my own belief, is a failed enterprise," he told Fierce Healthcare. "The market will take care of itself if you align interests around patients and price."
|
|
April 25, 2022 - Fierce Pharma
|
Days after throwing down $350 million to beef up biologics manufacturing in Indiana, high-flying CDMO Catalent is buying a cell therapy plant on the East Coast. |
|
April 26, 2022 - Fierce Healthcare
|
Three years ago, technology startup Biofourmis had raised $10 million in total funding. This week, the virtual care and digital medicine-focused company announced a massive $300 million cash injection to fuel its growth. |
|
April 27, 2022- Fierce Biotech
|
Pfizer is throwing its weight behind Zentalis Pharmaceuticals’ synthetic lethality candidate, making a $25 million investment in its new partner and agreeing to jointly advance the prospect through the clinic. |
|
April 28, 2022- Fierce Biotech
|
Oticon Medical’s ears must be burning after parent company Demant struck a deal to divest the implant business in a sale to fellow hearing technology developer Cochlear. |
|
Tanner was honored to serve as the presenting sponsor of The Max Foundation's annual Max Gala, and to help amplify the voices of cancer patients around the world. Through the support of many, the gala raised more than $260,000 in support of Max's mission to accelerate health equity. Learn more about Tanner's partnership with Max and the impacts of the Max Access Solutions program. |
|
Tanner Pharma announced last week its expansion to Ireland with the opening of a new office space in Cork, the country’s third largest city. The new location was selected after many months of travel and research by Tanner’s executive team.
|
|
The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.
|
|
|
|
|
|
|
